You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Directed Energy Environmental Decision Systems (DEEDS)
SBC: MZA ASSOCIATES CORP Topic: AF182033MZA proposes a Directed Energy Decision System (DEEDS) inspired by the considerable experience MZA has gained in system modeling and atmospheric characterization for effects modeling and our progress made under the initial Phase II contract. The approach relies on numerical weather prediction or real-time meteorological and turbulence measurements data input to Laser Environmental Effects Defini ...
SBIR Phase II 2023 Department of DefenseAir Force -
Scalable MXene Synthesis for Aerospace Applications
SBC: BALLYDEL TECHNOLOGIES INC. Topic: AF21ATCSO2During the Phase II effort, Ballydel Technologies will develop scalable and safe processes for the manufacture of MAX phase and MXene powders in 1Kg batch sizes. Additionally, our team will implement commercial-scale mixing procedures for the production
STTR Phase II 2023 Department of DefenseAir Force -
Persistent Wide-field Regional Geosynchonous Belt Surveillance
SBC: TAU TECHNOLOGIES LLC Topic: SF224D006This program addresses the Space Force need for an improved optical system to provide persistent location and change detection monitoring of GEO-belt satellite orbits. The RSOs (Resident Space Objects) can be in either stable and unstable orbits, and oft
SBIR Phase II 2023 Department of DefenseAir Force -
Additively Manufactured GTNANO(R) RadHard Imaging CubeSat
SBC: GOODMAN TECHNOLOGIES LLC Topic: SF224D027Goodman Technologies (GT) patented and patent pending additively manufactured (AM) nanocomposite materials, registered trademark GTNANO®, are dual-use and include AM silicon carbide mirrors and telescopes, and advanced radiation shielding that employs na
SBIR Phase II 2023 Department of DefenseAir Force -
Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention
SBC: FORTISCIENCE, INC. Topic: NHLBIProject Summary Project Title: Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention. Atherosclerosis affects more than 18 million Americans and is a major cause of cardiovascular diseases and acute cardiovascular events, such as heart attack and stroke. Current interventions include changes to diet and exercise, smoking cessation, and treatment with st ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing
SBC: EXHALIX LLC Topic: 300Project Summary/Abstract The proposed effort addresses the need for novel therapeutic tools that improve chronic wound healing outcome. Recent studies show that patients with diabetic foot ulcers have a 40% recurrence rate within 1 year after treatment and healing, nearly 60% within 3 years, and 65% within 5 years, while the 5-year mortality rate is exceeded only by lung cancer. Lower limb wounds ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Amino Acids and Pediatric Hepatic Steatosis
SBC: THE AMINO COMPANY LLC Topic: 3007. Project Summary/Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in North America (1). Hepatic steatosis (HS) is the hallmark of NAFLD (2). NAFLD may transition in sub-groups to chronic inflammation (non- alcoholic steatohepatitis, NASH), and ultimately to cirrhosis. HS is prevalent in all stages of NAFLD. 3-10% of all children in the US and 40-70% of obese ch ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
SBC: Nob Hill Therapeutics, Inc. Topic: 102Project SummaryLung cancer (LC) with over 2 million cases/year worldwide also remains the leading cause of cancer- related death in the US and Europe. Treating LC remains challenging due to ~60% of patients presenting with Stage IV disease, the heterogeneity of tumors with respect to genetic and epigenetic mechanisms that alter gene expression, and treatment-related resistance. Combining chemother ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
PET Imaging of Damaging Neuroinflammation in Alzheimer's Disease
SBC: EINSENCA INC. Topic: NIAAlzheimer's disease (AD) is a devastating and progressive disease without a cure. Neuroinflammation is now recognized as a key early event in the development of AD. Aberrant neuroinflammatory response activates immune cells that can increase oxidative stress, and oxidative stress can directly damage neurons and axons, cause demyelination, and break down the blood-brain barrier (BBB). Thus, damagin ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
GeoTGo: Equitable and inclusive tool for community-based geothermal development
SBC: ENVITRACE LLC Topic: C5407cGeothermal is a critical, yet underutilized, resource for our nation’s climate and energy goals. Geothermal, like other new technologies whose socioeconomic impacts are not fully understood, may cause disproportionately high adverse effects on disadvantaged communities. This is especially true if the process does not fully account for their socioeconomic and cultural interests and concerns. Unfo ...
SBIR Phase II 2023 Department of Energy